Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Malik M ParmarKuldeep Singh SachdevaPuneet K DewanKiran RadeSreenivas A NairRashmi PantSunil D KhapardePublished in: PloS one (2018)
India's initial MDR-TB patients' cohort treated under the RNTCP experienced poor treatment outcomes. To address the factors associated with poor treatment outcomes revealed in our study, a systematic multi-pronged approach would be needed. A series of policies and interventions have been developed to address these factors to improve DR-TB treatment outcomes and are being scaled-up in India.
Keyphrases
- multidrug resistant
- mycobacterium tuberculosis
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- prognostic factors
- randomized controlled trial
- mental health
- physical activity
- emergency department
- drug resistant
- patient reported outcomes
- hepatitis c virus
- cystic fibrosis
- hiv aids
- quality improvement
- adverse drug